Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma
Clinical trial NCT05057845 · RECRUITING
Trial details
- NCT number
- NCT05057845
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-26
- Primary completion
- 2026-09-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.